Pennwell web 200 200


June 8, 2010
AlloSorb™ is available in three types.
RESEARCH TRIANGLE PARK, North Carolina--RIEMSER, a leader in oral surgery technology, has announced the launch of AlloSorb™.AlloSorb™ is a cost-competitive allograft that provides a natural structure and framework to build healthy bone in the regeneration process. The product is a STERILE-R allograft accredited by the American Association of Tissue Banks. AlloSorb™ uses a sterilization and processing method, Allowash®, a patented technology that helps minimize the risk of disease transmission by facilitating the removal of cellular elements from musculoskeletal tissue without degrading the tissues’ structural integrity. AlloSorb™ is low-dose irradiated. Furthermore, to achieve patient safety, the manufacturer’s screening process for donors meets or exceeds FDA regulations and AATB standards. AlloSorb™ is available in three types of particulate--mineralized cancellous, demineralized cortical, and mineralized cortical--in .5 cc, 1.0 cc, and 2.0 cc vials. It will soon be available in block form. “Our customers include oral surgeons, periodontists, and other implantologists who want RIEMSER to serve as a one-stop supplier for all their bone grafting needs, which is why we are pleased to add this safe, cost-competitive allograft product to our growing line,” says Vince Ellero, Director, National Sales. For more information, go to read more about RIEMSER, go to RIEMSER.To comment on this product, go to